PEIX, Pacific Ethanol, BIOF, Bio Fuel Energy
BIOF: a spectacular success for our members. The stock has gained a whopping 300% since the Alert!
BIOF - BioFuel Energy produces Ethanol and its co-products in the United States. The company offers dried and wet distillers grains with solubles, and carbon dioxide. It operates two ethanol production facilities located in Wood River, Nebraska and Fairmont, Minnesota with a combined production capacity of approximately 220 million gallons a year.
PEIX - Pacific Ethanol, produces and markets low carbon renewable fuels in the western United States. The company offers ethanol and its co-products, including wet distillers grains. It also provides transportation, storage, and delivery of ethanol through third-party service providers.
BioFuel Energy (BIOF) and Pacific Ethanol (PEIX) are the only two large remaining Ethanol producers in the country.
BIOF and PEIX both are bouncing back from historic lows. We were among the first to notice the Low Valuation of these stocks.
You are missing the Premium Alerts! Sign-up, Get Alerts that MakeMoney!®
we get compensated by the companies we feature. Always Read the full Disclosure/Disclaimer. Thanks
CBRX, Columbia Labs. NEPT, Neptune Technologies
CBRX - Columbia Labs, is focused on development and commercialization of women?s healthcare and endocrinology products. It develops products by utilizing its bioadhesive drug delivery technologies.
The company offers bioadhesive vaginal gel products that provide solutions for infertility, pregnancy support, amenorrhea, gynecologic, and other medical conditions. Its products include CRINONE and PROCHIEVE, which are progesterone gels; and STRIANT, a testosterone buccal system. Bouncing back from 52WK LOWS.
NEPT - Neptune Technologies & Bioressources is a biotechnology company that makes products derived from marine biomasses for the nutraceutical, pharmaceutical, and cosmetic industries.
Neptune product prevents skin damages caused by chronic exposure to UV radiation; reduces the physical and emotional symptoms associated with premenstrual syndrome; provides relief from dysmenorrheal; controls hyperlipidemia by reducing the cholesterol levels; reduces chronic inflammation and osteoarthritis disease; and controls attention deficit hyperactivity disorders. Very Attractive, keep an eye!
You are missing the Premium Alerts! Sign-up, Get Alerts that MakeMoney!®
we get compensated by the companies we feature. Always Read the full Disclosure/Disclaimer. Thanks
AVII, Avi Bio Pharma, Profile, Summary
AVI Bio Pharma is a leader in RNA based technology, the company is developing a range of potential therapeutic compounds that target different types of RNA. Unlike most other RNA-based approaches, AVI’s technology has been used to directly target both messenger RNA (mRNA) and precursor messenger RNA (pre-mRNA) to either down-regulate or up-regulate targeted genes or proteins.
This Bio-pharmaceutical company has several drugs in the pipeline, and strategic alliances with leading institutions and pharmaceutical firms. The company also has collaborative agreements with select academic, governmental and non-governmental organizations. Very Attractive, Medium to Long Term, Bouncing Back from 52WK Lows.
You are missing the Premium Alerts! Sign-up, Get Alerts that MakeMoney!®
we get compensated by the companies we feature. Always Read the full Disclosure/Disclaimer. Thanks
VALV, Shengkai Innovations, XOMA, Xoma Ltd.
VALV - Shengkai Innovations makes ceramic valves and components for industrial. It provides ceramic valves in various categories, including gate valves, ball valves and adjustable cut-off valves.
The company's primary customers are electric power, petrochemical, chemical, aluminum, and metallurgy industries. The company is expected to increase its global market share. Stock is bouncing back from 52WK lows, keep an eye!
XOMA – XOMA is a biopharmaceutical company, engaged in the development of therapeutic antibodies to treat inflammatory, autoimmune, infectious, and oncological diseases. The company receives royalties on products, such as LUCENTIS for the treatment of neovascular (wet) age-related macular degeneration; and CIMZIA for the treatment of rheumatoid arthritis and Crohn's disease.
XOMA products include HCD122, a human anti-CD40 antagonist antibody for the treatment of B-cell mediated diseases, including malignancies and autoimmune diseases in Phase I/II clinical trials for various indications. In addition, it licenses proprietary technologies relating to bacterial expression of recombinant pharmaceutical products to biotechnology and pharmaceutical companies. Undervalued, Bouncing back from 52WK LOWS.
You are missing the Premium Alerts! Sign-up, Get Alerts that MakeMoney!®
we get compensated by the companies we feature. Always Read the full Disclosure/Disclaimer. Thanks
- PEIX,Pacific Ethanol,Profile,Summary. | ICAD, icad inc, Profile,Summary.
- DSTI, DayStar Technologies, Profile,Summary | SATC, Satcon Technology,Profile,Summary
- Stocks to Watch: TRID,Trident Microsystems, GRVY, Gravity
- GEFI, GEO FINANCE, PROFILE,SUMMARY
- Stocks to Watch, COCO:Corinthian Colleges | ADAT:Authentidate Holding
- Hot Stocks to Watch GEFI, IKCC, 11-07-2011
- Hot Stocks to Watch CYDE, OPWV 11-04-2011
Feed Entries
